1987
DOI: 10.1159/000249181
|View full text |Cite
|
Sign up to set email alerts
|

Eicosanoids in Psoriasis – 15-HETE on the Stage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1988
1988
2009
2009

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(4 citation statements)
references
References 20 publications
(21 reference statements)
0
4
0
Order By: Relevance
“…A further novel, and intriguing, finding was the significant UVB up-regulation of the anti-inflammatory eicosanoid 15-HETE, exhibiting a later response with mean levels observed to double between 48 and 72 h and potentially rising beyond 72 h. This 15-LOX metabolite has been shown to inhibit the synthesis of proinflammatory eicosanoids PGE 2 and 12-HETE in in vitro models (14 , 44) and to inhibit the activity of 12-LOX in epidermis (45) and 5-LOX in neutrophils (44) . Hence, the later elevation of this mediator could reflect a role in the resolution of sunburn, including limitation of the neutrophil influx.…”
Section: Discussionmentioning
confidence: 99%
“…A further novel, and intriguing, finding was the significant UVB up-regulation of the anti-inflammatory eicosanoid 15-HETE, exhibiting a later response with mean levels observed to double between 48 and 72 h and potentially rising beyond 72 h. This 15-LOX metabolite has been shown to inhibit the synthesis of proinflammatory eicosanoids PGE 2 and 12-HETE in in vitro models (14 , 44) and to inhibit the activity of 12-LOX in epidermis (45) and 5-LOX in neutrophils (44) . Hence, the later elevation of this mediator could reflect a role in the resolution of sunburn, including limitation of the neutrophil influx.…”
Section: Discussionmentioning
confidence: 99%
“…Intracellular FA transport in human epidermis is performed by specific carriers, such as the epidermal-type fatty acid-binding protein (E-FABP) [5][6][7] and the recently described FA-p34 complex composed of the Ca# + -binding proteins (CaBPs) S100A8 and S100A9 [8]. The fact that E-FABP and FA-p34 are highly overexpressed in lesional psoriatic skin [8][9][10] is in line with the discovery of an altered epidermal Ca# + gradient [11] and an altered FA transport\metabolism associated with this disease [12][13][14]. S100A7, a CaBP of unknown biological function, is weakly expressed in the granular layer of normal skin, whereas it is highly expressed in the cytosol and the particulate fraction of psoriatic epidermis [15][16][17].…”
Section: Introductionmentioning
confidence: 89%
“…Thus, S100A7 and EFABP could function to transport and/or metabolize fatty acids, including oleic acid (Hagens et al, 1999b). Other S100 proteins have also been implicated in fatty acid processing, including S100A8 and S100A9 (Kragballe and Voorhees, 1987;Fogh et al, 1989;Siegenthaler et al, 1997).…”
Section: S100a7 Colocalizes With A-actininmentioning
confidence: 99%